Pro Medicus, Ltd. · BIVA:PME/N

Pro Medicus, Ltd. financial statements

Pro Medicus, Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue261.7M212.9M161.4M124.9M93.5M67.9M56.8M50.1M35.9M31.6M
Cost of revenue50.5M309.0K39.2M32.5M23.2M21.2M355.0K1.41M220.0K521.0K
Gross profit211.1M212.6M122.2M92.4M92.9M46.7M56.4M48.7M35.7M31.1M
Research and development6.24M7.66M7.09M6.50M6.40M6.84M5.89M4.79M4.10M
Selling, general and administrative46.0M36.3M30.4M24.1M15.4M13.5M12.9M12.1M9.09M8.69M
Operating income196.1M157.6M112.2M83.9M62.4M42.4M30.1M25.5M14.8M14.9M
Depreciation and amortization8.06M7.24M8.51M834.0K813.0K803.0K845.0K6.08M4.94M4.28M
EBITDA204.2M164.8M120.7M84.7M63.2M43.2M30.9M31.6M19.7M19.2M
Interest expense1.94M1.12M386.0K649.0K538.0K5.00K684.0K463.0K777.0K
Income before tax377.5M163.3M116.5M86.1M63.1M42.9M30.0M26.1M15.3M13.4M
Income tax112.2M48.1M33.7M25.5M18.6M12.0M6.94M7.00M5.34M4.09M
Net income265.3M115.2M82.8M60.6M44.4M30.9M23.1M19.1M9.96M9.32M
Earnings per share, basic2.541.100.790.580.420.290.220.180.100.09

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents146.5M174.5M60.1M91.2M63.7M42.0M43.4M32.3M25.2M22.8M
Short-term investments104.1M34.6M95.4M30.2M26.9M19.8M19.8M8.00M14.0M0
Receivables100.4M64.2M48.1M40.7M27.4M24.4M17.0M19.2M8.20M6.55M
Inventory98.0K49.0K55.0K77.0K34.0K35.0K31.0K54.0K54.0K
Current assets356.1M280.1M206.6M163.8M119.8M87.6M61.5M52.5M34.4M30.2M
Property, plant and equipment2.77M2.38M2.19M2.60M3.01M2.85M503.0K352.0K283.0K
Total assets610.1M338.7M257.4M202.1M157.1M125.6M95.6M84.3M61.0M47.2M
Accounts payable1.09M1.41M1.74M1.03M1.64M872.0K835.0K705.0K565.0K446.0K
Current liabilities52.2M43.1M34.6M30.9M26.9M17.6M12.7M13.9M9.90M7.25M
Total debt2.23M2.25M2.07M1.85M2.28M2.62M2.28M7.63M
Total liabilities159.2M81.7M69.7M63.4M55.3M43.9M35.5M35.0M26.0M12.4M
Shareholders' equity450.9M257.0M187.7M138.8M101.7M81.7M60.2M49.3M35.1M34.8M
Shares outstanding104.7M104.6M104.7M104.6M104.6M104.6M104.5M104.4M104.3M104.1M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations127.5M111.3M86.8M62.5M61.6M38.8M31.4M24.7M13.9M14.8M
Capital spending-8.69M-7.38M-6.69M-6.45M-9.02M-7.69M-7.87M-342.0K-219.0K-80.0K
Free cash flow118.8M104.0M80.1M56.1M52.6M31.1M23.5M24.3M13.7M14.7M
Cash from investing-12.2M-6.58M-78.1M-7.56M-16.9M-27.2M-7.70M-7.30M-6.33M-6.13M
Cash from financing-75.6M-57.6M-39.8M-27.5M-23.3M-14.0M-12.3M-9.84M-5.13M-2.51M
Dividends paid-64.8M-49.1M-36.6M-26.1M-18.8M-13.5M-10.9M-9.84M-5.15M-3.08M
Share buybacks-10.1M-7.85M-2.77M-845.0K-4.02M-4.02M-842.0K-842.0K25.0K-73.0K
Change in cash39.0M47.4M-31.2M27.6M21.6M-1.37M11.1M7.08M2.46M5.67M